The MT-CO2 gene provides the code for subunit 2 of cytochrome c oxidase, which is essential for the function of the enzyme . The Cytochrome c oxidase complex facilitates the transfer of electrons from cytochrome c to oxygen . COII is one of the three subunits responsible for the functional core of cytochrome c oxidase . This subunit plays an essential role in transferring electrons from cytochrome c to the catalytic subunit 1's bimetallic center using its binuclear copper A center .
Cytochrome c oxidase is a large transmembrane protein complex with several metal prosthetic sites and multiple protein subunits . Subunit 2 has two transmembrane regions at its N-terminus, with the majority of the protein exposed to the periplasmic space or the mitochondrial intermembrane space . The substrate-binding site is located on MT-CO2, which also contains the binuclear copper A center, the primary electron acceptor in cytochrome c oxidase .
The full-length cDNA of COXII has been cloned from Sitophilus zeamais, featuring an open reading frame (ORF) of 684 bp encoding 227 amino acids . The predicted COXII protein has a molecular mass of 26.2 kDa with a pI value of 6.37 . Sequence analysis reveals high sequence identity with the COXII of other insect species .
Recombinant COXII with a 6-His tag can be purified using affinity chromatography with Ni(2+)-NTA agarose . Studies using UV-spectrophotometers and infrared spectrometers have demonstrated that recombinant COXII can catalyze the oxidation of the substrate Cytochrome C (Cyt c) . The recombinant protein, when expressed in E. coli, has a molecular weight of approximately 44 kD .
The cytochrome c oxidase complex consists of several conserved subunits.
| No. | Subunit name | Human protein | Protein description from UniProt | Pfam family with Human protein |
|---|---|---|---|---|
| 1 | Cox1 | COX1_HUMAN | Cytochrome c oxidase subunit 1 | Pfam PF00115 |
| 2 | Cox2 | COX2_HUMAN | Cytochrome c oxidase subunit 2 | Pfam PF02790, Pfam PF00116 |
| 3 | Cox3 | COX3_HUMAN | Cytochrome c oxidase subunit 3 | Pfam PF00510 |
| 4 | Cox4i1 | COX41_HUMAN | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | Pfam PF02936 |
| 5 | Cox4a2 | COX42_HUMAN | Cytochrome c oxidase subunit 4 isoform 2, mitochondrial | Pfam PF02936 |
| 6 | Cox5a | COX5A_HUMAN | Cytochrome c oxidase subunit 5A, mitochondrial | Pfam PF02284 |
| 7 | Cox5b | COX5B_HUMAN | Cytochrome c oxidase subunit 5B, mitochondrial | Pfam PF01215 |
| 8 | Cox6a1 | CX6A1_HUMAN | Cytochrome c oxidase subunit 6A1, mitochondrial | Pfam PF02046 |
| 9 | Cox6a2 | CX6A2_HUMAN | Cytochrome c oxidase subunit 6A2, mitochondrial | Pfam PF02046 |
| 10 | Cox6b1 | CX6B1_HUMAN | Cytochrome c oxidase subunit 6B1 | Pfam PF02297 |
| 11 | Cox6b2 | CX6B2_HUMAN | Cytochrome c oxidase subunit 6B2 | Pfam PF02297 |
| 12 | Cox6c | COX6C_HUMAN | Cytochrome c oxidase subunit 6C | Pfam PF02937 |
| 13 | Cox7a1 | CX7A1_HUMAN | Cytochrome c oxidase subunit 7A1, mitochondrial | Pfam PF02238 |
| 14 | Cox7a2 | CX7A2_HUMAN | Cytochrome c oxidase subunit 7A2, mitochondrial | Pfam PF02238 |
| 15 | Cox7a3 | COX7S_HUMAN | Putative cytochrome c oxidase subunit 7A3, mitochondrial | Pfam PF02238 |
| 16 | Cox7b | COX7B_HUMAN | Cytochrome c oxidase subunit 7B, mitochondrial | Pfam PF05392 |
| 17 | Cox7c | COX7C_HUMAN | Cytochrome c oxidase subunit 7C, mitochondrial | Pfam PF02935 |
| 18 | Cox7r | COX7R_HUMAN | Cytochrome c oxidase subunit 7A-related protein, mitochondrial | Pfam PF02238 |
| 19 | Cox8a | COX8A_HUMAN | Cytochrome c oxidase subunit 8A, mitochondrial P | Pfam PF02285 |
| 20 | Cox8c | COX8C_HUMAN | Cytochrome c oxidase subunit 8C, mitochondrial | Pfam PF02285 |
Subunits I and II constitute the enzyme complex's functional core. Electrons from cytochrome c are transferred via heme a and Cu(A) to the binuclear center comprising heme a3 and Cu(B).
Cytochrome c oxidase subunit 2 (ctaC) is a critical component of cytochrome caa3, which functions as a terminal enzyme in the respiratory electron transport chain. In Bacillus subtilis, ctaC has been conclusively demonstrated to be a lipoprotein with the N-terminal sequence exhibiting characteristic features of bacterial lipoproteins . The protein contains a cytochrome c domain with covalently bound heme that plays an essential role in electron transfer during oxidative phosphorylation. The functional protein integrates into the cell membrane, with its cytochrome c domain positioned on the outer side of the membrane where it can accept electrons from cytochrome c and transfer them to the catalytic center of the enzyme .
While ctaC (subunit II of cytochrome caa3) functions in a terminal oxidase complex, it differs substantially from subunits in other oxidase types such as cbb3-type oxidases. For instance, in cbb3-type oxidases, the analogous electron transfer role is performed by the CcoO subunit, which contains one c-type heme and is membrane-anchored . Unlike ctaC, which is a lipoprotein requiring specific post-translational processing, CcoO partners with CcoN (the catalytic subunit containing b-type hemes) to form the functional core of cbb3-type oxidases . Furthermore, ctaC in B. subtilis is unique in being one of only four main proteins (alongside QcrC, QcrB, and CccA) that contain covalently bound heme in the membrane fraction .
Research demonstrates that ctaC undergoes two critical post-translational modifications that impact its functionality:
Lipid modification: The protein is lipid-modified at its N-terminus by prolipoprotein diacylglyceryl transferase (Lgt).
Signal peptide cleavage: The signal peptide is removed by signal peptidase type II (Lsp).
Experimental evidence from B. subtilis mutants reveals that while covalent binding of heme to the cytochrome c domain occurs independently of these modifications, removal of the signal peptide is specifically required for the formation of functionally active enzyme . This indicates a complex maturation pathway where certain structural features can assemble without complete processing, but catalytic activity requires full maturation of the protein.
For robust detection and quantification of ctaC expression, a multi-method approach is recommended:
Radioactive Labeling Method:
Grow bacterial cells in the presence of radioactive 5-aminolevulinic acid (ALA), a heme biosynthetic precursor.
Isolate membrane fractions using ultracentrifugation.
Separate proteins using SDS-PAGE.
Visualize cytochrome c through autoradiography, as the covalently bound heme remains attached to the polypeptide despite SDS treatment .
Immunoblot Analysis Protocol:
Prepare membrane fractions from bacterial cultures.
Separate proteins using SDS-PAGE.
Transfer proteins to a membrane.
Probe with antibodies specific to the C-terminal peptide of ctaC.
Develop using appropriate secondary antibodies and detection systems .
Spectrophotometric Enzyme Activity Assay:
Isolate membrane fractions.
Measure cytochrome c oxidation activity spectrophotometrically.
Use reduced Saccharomyces cerevisiae cytochrome c (20 μM) as substrate.
Calculate activity as μmol of cytochrome c oxidized per mg of membrane protein per minute .
To generate and validate ctaC mutants for functional studies, follow this comprehensive approach:
Generation Strategy:
Design mutation strategies targeting specific domains (signal sequence, transmembrane domain, or cytochrome c domain).
For processing mutants, target genes in the post-translational modification pathway (lgt for lipid modification, lsp for signal peptide cleavage).
Use allelic replacement techniques to introduce mutations into the chromosome or complementation with plasmid-borne mutant alleles.
Validation Protocol:
Genetic verification: Confirm mutations by PCR and sequencing.
Protein expression analysis: Use immunoblotting to verify expression levels and apparent molecular weight (wild-type ctaC appears at ~38 kDa while unprocessed forms in lsp mutants appear at ~40 kDa) .
Heme incorporation: Verify cytochrome c domain assembly by radioactive labeling with [14C]ALA followed by SDS-PAGE and autoradiography .
Subcellular localization: Confirm membrane association through fractionation studies.
Functional assessment: Measure cytochrome c oxidase activity spectrophotometrically using reduced cytochrome c as a substrate .
| Strain Type | Relative Molecular Weight | Signal Peptide Status | Lipid Modification | Cytochrome c Oxidase Activity | Heme Binding |
|---|---|---|---|---|---|
| Wild-type | 38 kDa | Cleaved | Present | 100% | Normal |
| Lgt-deficient | 38 kDa + 39 kDa | Partially cleaved | Absent | 26% ± 8% | Normal |
| Lsp-deficient | 40 kDa | Uncleaved | Present | 5% ± 2% | Normal |
When establishing recombinant ctaC expression systems, the following controls are essential:
Essential Control Panel:
Empty vector control: To establish baseline expression and exclude effects from the expression system itself.
Wild-type ctaC expression: Serves as positive control for proper protein processing and functionality.
Non-functional ctaC mutant: A variant with documented loss of function helps validate assay sensitivity.
Processing pathway controls: Include strains with mutations in lgt and lsp genes to distinguish effects of different post-translational modifications .
Cytochrome caa3-deficient control: A strain completely lacking cytochrome caa3 (e.g., through deletion of catalytic subunits) serves as a negative control for activity assays .
Validation Measurements:
Monitor growth rates under different respiratory conditions
Compare cytochrome c oxidase activity levels
Analyze membrane-bound cytochrome content spectrophotometrically
Verify protein expression through immunoblotting
Confirm proper heme incorporation using radioactive labeling
When confronting contradictory data regarding ctaC localization and assembly, researchers should implement a systematic approach:
Contradiction Resolution Framework:
Validate experimental techniques: Ensure that membrane fractionation procedures are consistent and appropriate for the organism studied.
Cross-reference multiple detection methods: Compare results from immunoblotting, radioactive labeling, and spectroscopic analyses to identify technical artifacts .
Consider proteolytic processing: Examine the presence of cleavage products, such as the 28 kDa fragment observed in some studies, which may represent truncated but membrane-associated forms of ctaC .
Evaluate transfer efficiency: Note that different forms of ctaC (e.g., the 40-kDa unprocessed form) may transfer from gels to membranes with varying efficiency during immunoblotting, potentially leading to misinterpretation of relative quantities .
Implement consistency checks: Use parallel detection methods on the same samples, such as combining autoradiography with immunoblotting to verify that observed patterns represent the same protein population .
When analyzing cytochrome c oxidase activity data across wild-type and mutant strains, consider these statistical best practices:
Statistical Analysis Protocol:
Replicate design: Use a minimum of three biological replicates and three technical replicates per condition.
Normalization strategy: Express activity as a percentage of wild-type activity to allow comparison across experimental batches.
Error reporting: Present data with standard deviation or standard error of the mean as appropriate (e.g., 26% ± 8% activity for Lgt-deficient mutants) .
Statistical testing: Apply appropriate tests (e.g., ANOVA with post-hoc tests) to determine significance of differences between strains.
Correlation analysis: Examine relationships between protein expression levels (quantified from immunoblots) and enzyme activity to identify potential threshold effects.
A comprehensive statistical approach should include:
Testing for normal distribution of data
Assessment of homogeneity of variance
Application of parametric or non-parametric tests as appropriate
Correction for multiple comparisons when testing numerous mutant strains
Distinguishing direct from indirect effects in ctaC mutant studies requires a multi-faceted approach:
Differentiation Strategy:
Complementation testing: Reintroduce wild-type ctaC on a plasmid to confirm phenotype rescue.
Domain-specific mutations: Create targeted mutations affecting specific functions rather than null mutations.
Epistasis analysis: Examine double mutants combining ctaC mutations with mutations in interacting partners or assembly factors.
Temporal analysis: Monitor the progression of defects during cell growth to distinguish primary from secondary effects.
Comparative analysis: Contrast phenotypes with those of mutants in other cytochrome oxidase subunits to identify subunit-specific versus general assembly defects.
Analysis of Indirect Effects in Processing Mutants:
Data from processing pathway mutants (Lgt- and Lsp-deficient) demonstrate that while both show impaired cytochrome caa3 activity, the mechanisms differ. The Lsp-deficient mutant (with uncleaved signal peptide) retains only 5% activity despite normal heme binding, suggesting that signal peptide removal is critical for a post-assembly activation step rather than the initial protein folding or heme incorporation .
The relationship between ctaC processing and cytochrome caa3 activity shows both conserved and species-specific patterns:
Processing-Activity Relationship:
In B. subtilis, research demonstrates that enzyme activity is significantly impacted by processing defects, with specific contributions from different modification steps:
Signal peptide cleavage: The most critical step for activity, as Lsp-deficient mutants (which cannot cleave the signal peptide) retain only 5% of wild-type activity despite normal heme incorporation .
Lipid modification: Important but less critical than signal peptide cleavage, as Lgt-deficient mutants (lacking lipid modification) maintain 26% of wild-type activity .
This pattern suggests that while the cytochrome c domain can fold and incorporate heme independently of N-terminal processing, signal peptide removal is essential for establishing proper structural conformation or interactions within the complete cytochrome caa3 complex. This finding has significant implications for studies in other bacterial species, where the processing machinery may differ in specificity or efficiency.
Distinguishing between cytochrome c oxidase isoforms requires a combination of biochemical, spectroscopic, and genetic approaches:
Isoform Differentiation Protocol:
Spectroscopic fingerprinting:
Substrate specificity analysis:
Test oxidation rates with different electron donors (e.g., mammalian vs. yeast cytochrome c)
Determine kinetic parameters (Km, Vmax) for each substrate
Compare inhibition profiles with oxidase-specific inhibitors
Genetic verification:
Use knockout strains for specific oxidase subunits
Verify loss of specific spectroscopic signals in these strains
Perform genetic complementation to confirm specificity
SDS-PAGE mobility:
To investigate ctaC interactions with other respiratory chain components, researchers should employ these methodological approaches:
Interaction Study Framework:
Co-immunoprecipitation protocol:
Generate antibodies against ctaC or epitope-tag the protein
Solubilize membrane complexes using mild detergents
Immunoprecipitate ctaC and identify interacting partners by mass spectrometry
Verify interactions by reciprocal co-immunoprecipitation
Blue native PAGE analysis:
Solubilize membrane complexes under non-denaturing conditions
Separate intact respiratory complexes
Identify complex components through second-dimension SDS-PAGE or mass spectrometry
Compare complex assembly in wild-type versus processing mutants
Crosslinking studies:
Apply membrane-permeable crosslinkers to living cells
Isolate crosslinked complexes
Identify crosslinked products by immunoblotting or mass spectrometry
Map interaction domains through analysis of crosslinked peptides
Fluorescence resonance energy transfer (FRET):
Generate fluorescent fusion proteins for ctaC and potential partners
Monitor energy transfer in living cells as indication of protein proximity
Validate interactions through controls for non-specific association
These approaches collectively provide a comprehensive picture of ctaC's integration within the respiratory chain and how post-translational modifications affect its interactions with other components.
Several high-potential research directions emerge from current knowledge of ctaC: